Literature DB >> 25612768

Common statin side effects explain poor compliance.

Simon B Dimmitt1, Hans G Stampfer2, John B Warren3.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25612768      PMCID： PMC4500337          DOI： 10.1111/bcp.12594

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  8 in total

Review 1.  Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review.

Authors:  Mary A De Vera; Vidula Bhole; Lindsay C Burns; Diane Lacaille
Journal:  Br J Clin Pharmacol       Date:  2014-10       Impact factor: 4.335

Review 2.  Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis.

Authors:  M R Law; N J Wald; A R Rudnicka
Journal:  BMJ       Date:  2003-06-28

3.  Symmetrical analysis of risk-benefit.

Authors:  John B Warren; Simon Day; Peter Feldschreiber
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

4.  Intensive lipid lowering with atorvastatin in patients with stable coronary disease.

Authors:  John C LaRosa; Scott M Grundy; David D Waters; Charles Shear; Philip Barter; Jean-Charles Fruchart; Antonio M Gotto; Heiner Greten; John J P Kastelein; James Shepherd; Nanette K Wenger
Journal:  N Engl J Med       Date:  2005-03-08       Impact factor: 91.245

5.  Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database.

Authors:  Julia Hippisley-Cox; Carol Coupland
Journal:  BMJ       Date:  2010-05-20

6.  Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial.

Authors:  Jane Armitage; Louise Bowman; Karl Wallendszus; Richard Bulbulia; Kazem Rahimi; Richard Haynes; Sarah Parish; Richard Peto; Rory Collins
Journal:  Lancet       Date:  2010-11-08       Impact factor: 79.321

7.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

8.  Assessment of statin-associated muscle toxicity in Japan: a cohort study conducted using claims database and laboratory information.

Authors:  Chia-Hsien Chang; Makiko Kusama; Shunsuke Ono; Yuichi Sugiyama; Takao Orii; Manabu Akazawa
Journal:  BMJ Open       Date:  2013-04-11       Impact factor: 2.692
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.